Deal Feed International Reports: BioNano Genomics Raises $53M in Series C
BioNano Genomics, Inc., the leader in genome mapping, announced the completion of a $53 million Series C financing. Legend Capital and Novartis Venture Fund co-led the round and were joined by Federated Kaufmann Fund and Monashee Investment Management as new investors.
Existing investors Domain Associates, Battelle Ventures and Gund Investment Corporation also participated. Darren Cai, Ph.D., Executive Director at Legend Capital, and Campbell Murray, M.D., Managing Director at Novartis Venture Fund, joined BioNano's board of directors.
The capital raised will be used to expand commercialization efforts to grow the installed base and utilization of BioNano's Irys™ platform and to develop the next generation platforms and technology innovations.
Deal details sourced by the Deal Feed Team from VCNews Daily. (Opens in new window)
If you have any additional information about this or any other report featured on Deal Feed please email, [email protected], to contact our Deal Team.